Codexis (CDXS) Change in Receivables (2010 - 2019)
Codexis (CDXS) posted quarterly Change in Receivables of -$3.3 million for Q4 2019, down 227.04% year-over-year from $2.6 million in Q4 2018, and down 741.63% quarter-over-quarter from $514000.0 in Q3 2019.
Codexis (CDXS) Change in Receivables (2010 - 2019) Analysis & Trends
Codexis' Change in Receivables history runs 10 years deep, the most recent figure standing at -$3.3 million for Q4 2019.
- In Q4 2019, Change in Receivables fell 227.04% year-over-year to -$3.3 million; the TTM figure through Dec 2019 stood at -$2.5 million (down 162.71% YoY), while the FY2019 annual figure was -$2.5 million, down 162.71% from the prior year.
- Change in Receivables for Q4 2019 stood at -$3.3 million, down from $514000.0 in the prior quarter.
- The five-year high for Change in Receivables was $10.8 million in Q3 2015, with the low at -$6.3 million in Q4 2015.
- The 5-year median for Change in Receivables is -$460000.0 (2015), against an average of $193500.0.
- Peak annual rise in Change in Receivables reached 5389.34% in 2015, while the deepest fall reached 961.32% in 2015.
- Codexis' Change in Receivables stood at -$6.3 million in 2015, then gained by 3.79% to -$6.0 million in 2016, then surged by 158.62% to $3.5 million in 2017, then decreased by 26.69% to $2.6 million in 2018, then slumped by 227.04% to -$3.3 million in 2019.
- Business Quant data shows CDXS's Change in Receivables at -$3.3 million in Q4 2019, $514000.0 in Q3 2019, and -$791000.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -3.30 Mn |
| Dec 31, 2019 | -3.30 Mn |
| Sep 30, 2019 | 514,000.00 |
| Sep 30, 2019 | 514,000.00 |
| Jun 30, 2019 | -791,000.00 |
| Jun 30, 2019 | -791,000.00 |
| Mar 31, 2019 | 1.05 Mn |
| Mar 31, 2019 | 1.05 Mn |
| Dec 31, 2018 | 2.60 Mn |
| Dec 31, 2018 | 2.60 Mn |
| Sep 30, 2018 | -499,000.00 |
| Sep 30, 2018 | -499,000.00 |
| Jun 30, 2018 | 546,000.00 |
| Jun 30, 2018 | 546,000.00 |
| Mar 31, 2018 | -3.60 Mn |
| Mar 31, 2018 | -3.60 Mn |
| Dec 31, 2017 | 3.54 Mn |
| Dec 31, 2017 | 3.54 Mn |
| Sep 30, 2017 | -122,000.00 |
| Sep 30, 2017 | -122,000.00 |